InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,145.07
(
-1.98%
)
Post# of 252501
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119983
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 225912

Wednesday, 03/04/2020 9:14:40 AM

Wednesday, March 04, 2020 9:14:40 AM

Post# of 252501
EOLS comments on ITC preliminary proceedings, which were completed yesterday and may have gone badly for EOLS/Daewoong, according to anecdotal information:

https://www.globenewswire.com/news-release/2020/03/04/1995161/0/en/Evolus-Provides-Update-on-International-Trade-Commission-ITC-Case.html

The PR strikes me as “protesting too much.”

Note: The ITC action, brought by AGN/Medytox against EOLS/Daewoong, is separate from Medytox’s lawsuit against Daewoong in Korea. A loss in either of these cases could cause EOLS to lose access to it sole supply of botulinum toxin.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up